About Altimmune : Altimmune (NASDAQ: ALT) is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's lead candidate, pemvidutide, is a unique dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). For more information, please visit www.altimmune.com . Summary of Position : We are seeking a Director/Senior Director, MASH Project Management Lead, with hands-on experience conducting global clinical trials in metabolic dysfunction-associated steatohepatitis (MASH). This role will be responsible for the end-to-end execution of clinical studies, working closely with CROs, investigators, vendors, and internal cross-functional teams. Prior experience in global biopsy-confirmed MASH studies is strongly preferred. This role is ideal for someone who is a versatile professional, thrives in a fast-paced working environment, and is a dynamic leader. This role reports to the Vice President, Global Program Lead, and will play a key role in the development of pemvidutide for the treatment of MASH.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director